The Dual GIP and GLP ‐1 Receptor Agonist Tirzepatide Improves Cardiovascular Risk Biomarkers in Patients with Type 2 Diabetes: a Post‐Hoc Analysis

Authors

Keywords

Journal

Volume -, Issue -, Pages -

Publisher

Wiley

Online

2021-09-20

DOI

10.1111/dom.14553

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now